Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Interaction Studies

Introduction: The Power of the HA Tag Peptide

The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic, nine-amino acid epitope (sequence: YPYDVPDYA) that has become indispensable in molecular biology and proteomics. As a high-purity molecular biology peptide tag, it enables researchers to detect, purify, and elute HA-tagged fusion proteins with unrivaled specificity and efficiency. Its robust solubility profile (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water) and >98% purity, confirmed by HPLC and mass spectrometry, ensure consistent results in diverse experimental contexts. Whether you're probing protein-protein interactions, exploring exosome biology, or optimizing immunoprecipitation workflows, the Influenza Hemagglutinin epitope tag offers unmatched versatility and reproducibility.

Principle and Setup: How the HA Tag Sequence Transforms Experimental Design

The HA tag, derived from the influenza hemagglutinin protein, is a classic epitope tag for protein detection and purification. Its short sequence (YPYDVPDYA) is minimally immunogenic in mammalian systems, making it ideal for tagging recombinant proteins. When fused to a protein of interest, the HA tag enables specific detection via anti-HA antibodies, facilitating Western blotting, immunofluorescence, and immunoprecipitation assays.

One of the most transformative uses of the HA peptide is as a competitive elution reagent. By exploiting its high-affinity binding to anti-HA antibodies, the synthetic peptide can effectively displace HA-tagged proteins from antibody-coated beads or columns—a process known as competitive binding to Anti-HA antibodies. This allows for gentle, non-denaturing elution of intact protein complexes, preserving protein-protein interactions for downstream analyses such as mass spectrometry or functional assays.

Key Features and Storage Best Practices

• Sequence: YPYDVPDYA (influenza hemagglutinin epitope)
• Purity: >98% (HPLC and MS-verified)
• Solubility: ≥100.4 mg/mL in ethanol, ≥55.1 mg/mL in DMSO, ≥46.2 mg/mL in water
• Recommended storage: desiccated at -20°C; avoid long-term peptide solution storage

These properties allow seamless integration into a range of buffers and experimental settings, supporting both routine and advanced molecular workflows.

Step-by-Step Workflow: Enhancing Immunoprecipitation and Purification

Leveraging the HA tag nucleotide sequence and its encoded peptide product, researchers can streamline immunoprecipitation with Anti-HA antibody and downstream protein purification. Here’s a data-driven, optimized protocol utilizing APExBIO's Influenza Hemagglutinin (HA) Peptide:

1. Expression of HA-Tagged Proteins

1. Clone the HA tag DNA sequence (coding for YPYDVPDYA) in-frame with your protein of interest.
2. Transfect or transduce cells and allow sufficient expression time.

2. Cell Lysis and Preparation

1. Harvest cells and lyse under non-denaturing conditions to preserve protein-protein interactions.
2. Clarify lysates by centrifugation.

3. Immunoprecipitation with Anti-HA Antibody

1. Incubate lysate with Anti-HA Magnetic Beads or conventional anti-HA antibody-conjugated resin.
2. Wash beads thoroughly to remove non-specific binders.

4. Competitive Elution with HA Peptide

1. Prepare a fresh solution of HA tag peptide at 1–2 mg/mL in compatible buffer (e.g., PBS or Tris-buffered saline). Higher concentrations can be used for more challenging elutions.
2. Incubate beads with the peptide solution for 30–60 minutes at 4°C with gentle agitation.
3. Collect the supernatant containing eluted HA fusion proteins.

Quantitative studies have shown that competitive elution with the HA peptide preserves up to 90% of complex integrity compared to harsh chemical elution, as detailed in this analysis.

5. Downstream Analysis

1. Proceed with SDS-PAGE, Western blotting, functional assays, or mass spectrometry as needed.

This workflow is readily adaptable to high-throughput screening or exosome pathway research, as demonstrated in protein-protein interaction studies and translational research settings (see strategic guidance here).

Advanced Applications and Comparative Advantages

The versatility of the Influenza Hemagglutinin (HA) Peptide extends well beyond basic immunoprecipitation. In the context of emerging research on exosome biogenesis, such as the landmark study "RAB31 marks and controls an ESCRT-independent exosome pathway", HA-tagged fusion proteins have been pivotal in dissecting the sorting and secretion mechanisms of membrane proteins like EGFR.

Exosome Research: Mapping Protein Sorting Pathways

In the referenced Cell Research paper, researchers used HA-tagged constructs to trace the trafficking of receptor tyrosine kinases and flotillin proteins within multivesicular endosomes (MVEs). Using the HA tag as a molecular beacon, they performed competitive elution to isolate intact protein complexes, enabling high-resolution proteomic analysis of ESCRT-independent exosome pathways. This approach illuminated the dual role of RAB31 in both ILV formation and MVE stabilization, supporting the growing consensus that the HA tag peptide is essential in modern exosome studies.

Protein-Protein Interaction Studies

As described in "Influenza Hemagglutinin (HA) Peptide: Next-Gen Tag for Quantitative Protein-Protein Interaction Studies", the high-affinity binding and exceptional purity of the HA fusion protein elution peptide facilitate reproducible quantification of dynamic protein networks. Compared to traditional tags, the HA system offers:

• Minimal background due to short, unique sequence
• Efficient competitive elution for intact complex recovery
• Compatibility with a range of detection and capture antibodies

Complementary Insights from the Literature

• High-purity epitope tag workflows further validate the reproducibility and benchmark status of APExBIO’s A6004 product, highlighting its impact on robust protein purification.
• Advanced insights for exosome research expand on how the HA peptide underpins new precision proteomics strategies in vesicle biology.

Data-Driven Performance

Empirical studies routinely report recovery rates >80% for HA-tagged fusion proteins with negligible non-specific background, outperforming comparable epitope tags in immunoprecipitation and competitive elution workflows. The high solubility and chemical stability of the peptide ensure reliable results across a spectrum of buffer systems and experimental temperatures.

Troubleshooting and Optimization Tips

Even with a robust system, optimizing immunoprecipitation and protein purification tag workflows is crucial for reproducibility. Here are targeted tips based on user feedback and published benchmarks:

• Incomplete Elution: Increase the HA peptide concentration up to 5 mg/mL or extend incubation time. Ensure the peptide is freshly prepared and fully solubilized in your buffer of choice.
• High Background: Use stringent washing buffers (e.g., high-salt or detergent-containing) after immunoprecipitation but before elution. Pre-clear lysates with control beads.
• Protein Degradation: Include protease inhibitors throughout the workflow and keep samples on ice when possible. Avoid repeated freeze-thaws of peptide stock.
• Low Recovery: Verify expression of the HA-tagged protein by Western blot prior to immunoprecipitation. Confirm that the ha tag sequence is in-frame and accessible on the fusion protein.
• Antibody Specificity: Use validated anti-HA antibodies or magnetic beads compatible with the HA peptide’s sequence. Not all clones exhibit equal affinity.

For more nuanced optimization, consult the troubleshooting sections in this comparative guide, which details how APExBIO’s formulation minimizes batch variability and maximizes reproducibility.

Future Outlook: Expanding the Frontier of Epitope Tag Utility

The strategic integration of the Influenza Hemagglutinin (HA) Peptide as a protein purification tag and epitope tag for protein detection continues to fuel innovation at the intersection of molecular biology and translational research. With the ongoing evolution of exosome biology, as highlighted in the RAB31/EGFR study, the HA tag nucleotide sequence and its encoded peptide are poised to remain central tools for dissecting complex signaling cascades, exploring non-canonical secretion pathways, and mapping protein networks in disease models.

Emerging trends include the use of the HA tag in multiplexed proteomics, live-cell imaging (via split-fluorescent constructs), and single-vesicle analysis. With APExBIO’s trusted supply chain and rigorous QC, the A6004 HA peptide is set to empower researchers to push the boundaries of quantitative and precision biology in the years to come.

Conclusion

The Influenza Hemagglutinin (HA) Peptide by APExBIO offers unmatched utility as a molecular biology peptide tag, delivering high purity, solubility, and reproducibility for applications spanning immunoprecipitation, protein-protein interaction studies, and exosome research. Its competitive binding to Anti-HA antibodies ensures efficient, gentle elution of HA fusion proteins, supporting next-generation workflows and high-impact discoveries in molecular and translational biology. As research advances, the HA peptide remains a gold-standard choice for precision and reliability in protein detection and purification.